SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001401914-20-000007
Filing Date
2020-01-13
Accepted
2020-01-13 07:17:59
Documents
8
Period of Report
2020-01-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dare8-k.htm 8-K 35121
2 EXHIBIT 99.1 exhibit991.htm EX-99.1 17241
3 exhibit991001.jpg GRAPHIC 191878
4 exhibit991002.jpg GRAPHIC 213886
5 exhibit991003.jpg GRAPHIC 259040
6 exhibit991004.jpg GRAPHIC 290859
7 exhibit991005.jpg GRAPHIC 152248
8 exhibit991006.jpg GRAPHIC 27384
  Complete submission text file 0001401914-20-000007.txt   1617749
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36395 | Film No.: 20522763
SIC: 2834 Pharmaceutical Preparations